Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06300450 · ClinicalTrials.gov registry record · NA
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
A NA study of Peripheral Artery Disease and Dyslipidemias, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06300450: Recruiting NA study of Peripheral Artery Disease and Dyslipidemias, sponsored by Brigham and Women's Hospital.
NCT06300450 is a NA study of Peripheral Artery Disease and Dyslipidemias that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 400 participants, above the 119-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (236% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06300450, a NA study of Peripheral Artery Disease and Dyslipidemias, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-center, 400-patient, randomized controlled trial assesses the impact of a patient- and provider-facing EPIC Best Practice Advisory (BPA; alert-based computerized decision support tool) to increase guideline-directed utilization of statin and statin-alternative oral LDL-C lowering therapies in patients with PAD who are not being prescribed LDL-C-lowering therapy.
Primary Outcome
The frequency of prescription of oral LDL-C-lowering therapy will be assessed using a report from the medical record
Conditions Studied
Interventions
- BEHAVIORAL Computer Alert
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
What NCT06300450 shows while recruiting
NCT06300450 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 119-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (236% higher).
The record links to 3 conditions, with Peripheral Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Computer Alert is the first listed.
NCT06300450 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06300450 about?
NCT06300450 is a clinical study titled "Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy". This single-center, 400-patient, randomized controlled trial assesses the impact of a patient- and provider-facing EPIC Best Practice Advisory (BPA; alert-based computerized decision support tool) to increase guideline-directed utilization of statin and statin-alternative oral LDL-C lowering therapi...
What is the current status of trial NCT06300450?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2023-03-01. Estimated completion is 2026-07-30.
What conditions does trial NCT06300450 study?
This clinical trial studies the following conditions: Peripheral Artery Disease, Dyslipidemias, Peripheral Vascular Diseases.
What interventions are being tested in trial NCT06300450?
The interventions under investigation include: Computer Alert (BEHAVIORAL).
Who is sponsoring clinical trial NCT06300450?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06300450 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06300450's enrollment target sits among peer trials
400 3rd of 50 higher than 48 of 50 other Peripheral Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peripheral Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
RECRUITING · NA
-
BEETroot Juice to Reverse Functional Impairment in PAD
RECRUITING · NA
-
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
RECRUITING · NA
-
The THOR IDE Study
RECRUITING · NA
-
Leg Heat Therapy in Peripheral Artery Disease
RECRUITING · NA
-
Oxygen-guided Supervised Exercise Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI